Latest News about MRTX
Recent news which mentions MRTX
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
From Benzinga
Biotech stocks get a boost, or plunge, as new clinical data is shared before major cancer meeting
May 27, 2022
From MarketWatch
Mid-Morning Market Update: Markets Open Higher; US Goods Trade Deficit Narrows In April
May 27, 2022
From Benzinga
From Benzinga
Even this pessimistic Bank of America strategist says the bear-market bandwagon has room to charge ahead
May 27, 2022
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies
April 13, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
From Benzinga
56 Biggest Movers From Yesterday
February 17, 2022
From Benzinga
Why Mirati Therapeutics Stock Is Plunging Today
February 16, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
February 16, 2022
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
From Benzinga
Mirati Therapeutics' Adagrasib Application Under FDA Review For Lung Cancer Setting
February 16, 2022
Tickers
MRTX
From Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
From Benzinga
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.